EBV Ea-D (0261) Antibody from Santa Cruz Biotechnology, Inc.

Yes, the EBV Ea-D antibody has been utilized in Western blot analysis as documented in multiple studies, including those by Chang et al. (2017) and Chen et al. (2021), where it was employed to detect lytic proteins associated with Epstein-Barr virus.

The EBV Ea-D antibody has been shown to work in immunofluorescence applications, as indicated in the studies by Harper et al. (2024) and Hartman-Houstman et al. (2024), where it was used to visualize viral proteins in infected cells.

The EBV Ea-D antibody specifically targets the early lytic protein Ea-D (also known as BMRF1), which is crucial for the lytic cycle of Epstein-Barr virus, as highlighted in the research by Hartman-Houstman et al. (2024).

Yes, studies have indicated that the EBV Ea-D antibody can be used to explore the connection between the lytic cycle of EBV and cellular stress responses, as seen in the work by Chen et al. (2021), which discusses the role of the unfolded protein response during EBV lytic replication.